Successful liver transplantation in a patient with Budd-Chiari syndrome caused by homozygous factor V Leiden

Liver Transplantation

Volumn 6, Issue 5, 2000, Pages 654-656

  Tan, Henkie P ^a,b   Markowitz, Jay S ^a,b   Maley, Warren R ^a,b   Merritt, William T ^a,b   Klein, Andrew S ^a,b  

^a CSB (M/C 958)   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BUDD CHIARI SYNDROME; CADAVER DONOR; CASE REPORT; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; GRAFT PATENCY; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; PATHOGENESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; RECIPIENT; SCREENING TEST; SERODIAGNOSIS; THROMBOGENESIS; THROMBOPHILIA; VEIN BLOOD FLOW; VEIN THROMBOSIS;

EID: 0033812671     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2000.7575     Document Type: Article

References (13)

1. Mutation in blood coagulation factor V associated with resistance to activated protein C
2. Resistance to activated protein C as a basis for venous thrombosis
3. Epidemiology of factor V Leiden: Clinical implications
4. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis
5. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
6. Budd-Chiari syndrome associated with oral contraceptive steroids: Review of treatment of 47 cases
7. Budd-Chiari syndrome recurring in a transplanted liver
8. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation
9. Acute Budd-Chiari syndrome treated by liver transplantation in a woman homozygous for factor V Leiden
10. Acute Budd-Chiari syndrome with fulminant hepatic failure in a pregnant woman with factor V Leiden mutation
11. Budd-Chiari syndrome in a patient with factor V Leiden - Successful treatment by TIPSS placement followed by liver transplantation
12. Secretable human platelet-derived factor V originates from the plasma pool
13. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation